Encompass Health Corporation (EHC)

Eastside Rehabilitation Hospital now open in GeorgiaJune 9, 2026 1:00 PM
PR Newswire (US) The 40-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and Piedmont.BIRMINGHAM, Ala. and LOGANVILLE, Ga., June 9, 2026 /PRNewswire/ -- Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, and Piedmont, the largest healthcare system in the state of Georgia, today announced the opening of Eastside Rehabilitation Hospital in Loganville, Georgia. The 40-bed inpatient rehabilitation hospital is now accepting patients. "We're pleased to once again partner with Piedmont to address the growing need for inpatient rehabilitation care in Georgia," said Ronnie Wagley, president of Encompass Health's South Atlantic region. "This new, state-of-the-art hospital provides convenient access for residents in Gwinnett County and surrounding areas, allowing them to recover from serious illness or injury closer to home."The more than 52,000-square-foot hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients receive a minimum of three hours of intensive therapy five days each week, frequent physician visits and 24-hour nursing care."We're grateful for our partnership with Encompass Health, and I'd like to thank everyone involved for helping make this bold vision a reality," said Larry Ebert, CEO of Piedmont Eastside Medical Center. "Through this partnership, we're expanding access to our nationally recognized inpatient rehabilitation program for families in Gwinnett and surrounding counties."Hospital amenities include all private patient rooms, a spacious therapy gym featuring state-of-the-art technologies, an activities of daily living suite, in-house dialysis suite, therapy courtyard, dining room, in-house pharmacy and dayroom areas. An interdisciplinary team of highly specialized nurses, therapists and physicians creates customized treatment plans to meet each patient's unique recovery goals.The hospital is Encompass Health's ninth hospital in Georgia and eighth joint venture hospital with Piedmont. The joint venture partnership between Encompass Health and Piedmont also includes Rehabilitation Hospital of Newnan, Rehabilitation Hospital of Henry, Rehabilitation Hospital of Phenix City, Rehabilitation Hospital of Columbus, Rehabilitation Hospital of Atlanta, Rehabilitation Hospital of Augusta and Rehabilitation Hospital of Athens.About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 176 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from major injuries or illnesses, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.About Piedmont 
Piedmont is empowering Georgians by changing healthcare. We continue to fuel Georgia's growth through safe, cost-effective, high-quality care close to home through an integrated healthcare system that provides a hassle-free, unified experience. We are a private, not-for-profit organization that for centuries has sought to make a positive difference in every life we touch in the communities we serve. Across our 2,000 physical locations we care for more than 4.5 million patients and serve communities that comprise 85 percent of Georgia's population. This includes 27 hospitals, 122 immediate care locations, 1,875 Piedmont Clinic physician practices and more than 3,900 Piedmont Clinic members. Our patients conveniently engage with Piedmont online, as they scheduled more than 657,000 online appointments and over 239,000 virtual visits. With more than 50,000 care givers we are the largest Georgia-based private employer of Georgians, who all came for the job, but stayed for the people. In 2024 and 2023, Piedmont has earned recognition from Newsweek as one of America's Greatest Workplaces for Diversity and also as one of America's Greatest Workplaces for Women. In 2022, Forbes ranked Piedmont on its list of the Best Large Employers in the United States. Piedmont provided more than $844 million in community impact in Fiscal Year 2025.For more information, or to book your next appointment, visit piedmont.org. Encompass Health media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.com   Piedmont media contact:
Megan Joseph | 678-245-1263
megan.joseph@piedmont.org View original content to download multimedia:https://www.prnewswire.com/news-releases/eastside-rehabilitation-hospital-now-open-in-georgia-302795548.htmlSOURCE Encompass Health Corp. Original: Eastside Rehabilitation Hospital now open in Georgia

Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West VirginiaMay 29, 2026 8:00 AM
PR Newswire (US) BIRMINGHAM, Ala. and BRIDGEPORT, W.Va., May 29, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia. The hospital will be an expanded relocation of Encompass Health's former 19-bed unit within the WVU Medicine United Hospital Center. "We're thrilled to expand access to inpatient rehabilitation care for patients in Bridgeport and surrounding communities," said Abe Sims, president of Encompass Health's MidAtlantic region. "The need for our services has increased with continued growth in the area, and we look forward to serving more patients closer to home in this new, freestanding hospital."The hospital will feature all private patient rooms, a state-of-the-art therapy gym equipped with advanced rehabilitation technologies, an activities of daily living suite, an in-house dialysis suite, a dining room, a pharmacy and an outdoor therapy courtyard.The hospital will serve patients recovering from debilitating illnesses and injuries, including stroke and other neurological conditions, brain and spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will provide physical, occupational and speech therapies to help patients restore function and improve quality of life. Care will be delivered by an interdisciplinary team of specialized nurses, therapists and physicians.Encompass Health's 19-bed unit within the WVU Medicine United Hospital Center is now closed, but Encompass Health Rehabilitation Hospital of Morgantown has temporarily expanded its capacity to provide continuity of care for patients during construction of the new hospital in Bridgeport.About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from major injuries or illnesses, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com and follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches or other incidents affecting the proper operation, availability or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact: 
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-to-build-36-bed-inpatient-rehabilitation-hospital-in-bridgeport-west-virginia-302785306.htmlSOURCE Encompass Health Corp. Original: Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia

Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028May 14, 2026 4:33 PM
PR Newswire (US) BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 4.500% senior notes due 2028 (the "2028 Notes"). The redemption price will be 100.0% of par, plus accrued and unpaid interest to the redemption date of June 13, 2026, pursuant to the terms of the 2028 Notes. Since June 13, 2026 is not a business day, the redemption price will be paid on the next business day, June 15, 2026. As a result of this redemption, the Company expects to record an approximate $3.2 million loss on early extinguishment of debt in the second quarter of 2026. As of May 14, 2026, the aggregate principal amount of the 2028 Notes outstanding was $800 million. The information contained in this press release does not constitute a notice of redemption of the 2028 Notes. Holders of the 2028 Notes should refer to the notice of redemption delivered to the registered holders of the 2028 Notes by Computershare Trust Company, National Association, the trustee with respect to the 2028 Notes.About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-looking statements
Statements contained in this press release which are not historical facts are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant market disruption; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.Media contact: 
Polly Manuel | 205-970-5912
Media@encompasshealth.com Investor relations contact:
Mark Miller | 205-970-5860
Mark.Miller@encompasshealth.com    View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-issues-notice-for-partial-redemption-of-its-4-500-senior-notes-due-2028--302772889.htmlSOURCE Encompass Health Corp. Original: Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028

Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offeringMay 14, 2026 4:15 PM
PR Newswire (US) BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034 (the "Notes") at a price of 100% of the principal amount thereof. The Company will pay interest on the Notes semiannually in arrears on June 1 and Dec. 1 of each year, beginning on Dec. 1, 2026. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. This offering is expected to close on May 29, 2026, subject to customary closing conditions. The Company intends to use the net proceeds from this offering, together with available cash on hand, to redeem at par $400 million in aggregate principal amount of its outstanding 4.500% Senior Notes due 2028, to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility and to pay certain related fees and expenses in connection with the foregoing.The Notes have been offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release shall not constitute a notice of redemption with respect to the notes to be redeemed.About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Forward-looking statements 
Statements contained in this press release which are not historical facts, such as the completion of the private offering of the Notes and the use of proceeds from the offering, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Notes; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.Media contact:
Polly Manuel | 205.970.5912 
Media@encompasshealth.com Investor relations contact:
Mark Miller | 205.970.5860
Mark.Miller@encompasshealth.com  View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-pricing-of-500-million-of-senior-notes-due-2034-in-a-private-offering-302772871.htmlSOURCE Encompass Health Corp. Original: Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, IdahoMay 11, 2026 4:30 PM
PR Newswire (US) BIRMINGHAM, Ala., and POST FALLS, Idaho, May 11, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 50–bed inpatient rehabilitation hospital in Post Falls, Idaho. The hospital will serve patients recovering from debilitating illnesses and injuries, including stroke and other neurological conditions, brain and spinal cord injuries, amputations and complex orthopedic issues. In addition to 24–hour nursing care, the hospital will provide physical, occupational and speech therapies to help patients restore function and improve their quality of life. Care will be delivered by specialized nurses, therapists and physicians.The hospital will include private patient rooms, a large therapy gym equipped with advanced rehabilitation technology, an activities of daily living suite, an in–house dialysis suite, a dining room, a pharmacy and an outdoor therapy courtyard."We're excited to expand Encompass Health's presence in Idaho to serve patients from Post Falls, Coeur d'Alene and surrounding areas," said Kim Steward, president of Encompass Health's West region. "Kootenai County is one of the fastest–growing regions in the state and the nation, and the community is already underserved in inpatient rehabilitation. This hospital will help meet that growing need by bringing high–quality, specialized care closer to home."The hospital is expected to open in 2028 and will be part of Encompass Health's national network of inpatient rehabilitation hospitals. It will be the Company's second location in Idaho, joining its existing hospital in Boise.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10–K for the year ended December 31, 2025, and Form 10-Q for the quarter ended Mar. 31, 2026.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact: 
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-plans-to-build-a-50-bed-inpatient-rehabilitation-hospital-in-post-falls-idaho-302768556.htmlSOURCE Encompass Health Corp. Original: Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Post Falls, Idaho

Encompass Health Rehabilitation Hospital of Concordville now open in PennsylvaniaMay 5, 2026 4:30 PM
PR Newswire (US) BIRMINGHAM, Ala. and GLEN MILLS, Pa., May 5, 2026 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Concordville in Concord Township in Delaware County, Pennsylvania. The 50-bed inpatient rehabilitation hospital is now accepting patients. The more than 66,000-square-foot, two-story, freestanding hospital provides essential rehabilitation services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain functional ability, independence and quality of life. Patients receive a minimum of three hours of intensive physical, occupational and/or speech therapy five days each week, as well as frequent physician visits and 24-hour nursing care. An interdisciplinary team of highly specialized nurses, therapists and physicians create customized treatment plans to meet each patient's unique recovery goals."We are excited to open Encompass Health Concordville, bringing comprehensive rehabilitation care closer to home for patients in the community," said Mat Gooch, president of Encompass Health's Northeast region. "Our dedicated team of clinicians looks forward to making a meaningful difference in patients' lives through personalized rehabilitation that improves both function and quality of life."Designed with patients' needs in mind, the hospital will offer a range of amenities, including all private patient rooms; two state-of-the-art therapy gyms equipped with advanced rehabilitation technologies for all mobility levels; an activities of daily living suite with real-world simulated spaces; an in-house dialysis suite; a landscaped therapy courtyard with recreational areas; a dining room; an in-house pharmacy; and multiple dayroom areas.Encompass Health Concordville is the Company's 10th location in Pennsylvania, with plans to open an additional hospital in Lower Providence later this year.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Encompass Health media contact:
Polly Manuel | 205-970-5912
Media@encompasshealth.com View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-rehabilitation-hospital-of-concordville-now-open-in-pennsylvania-302762939.htmlSOURCE Encompass Health Corp. Original: Encompass Health Rehabilitation Hospital of Concordville now open in Pennsylvania

Encompass Health reports results for first quarter 2026April 30, 2026 4:20 PM
PR Newswire (US)

Increases full-year guidanceBIRMINGHAM, Ala., April 30, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the first quarter ended March 31, 2026.







Summary results




Growth
Q1 2026
Q1 2025
Dollars
Percent
(In Millions, Except Per Share Data)Net operating revenue$     1,586.6
$     1,455.4
$    131.2
9.0 %Income from continuing operations attributable to
     Encompass Health per diluted share1.77
1.48
0.29
19.6 %Adjusted earnings per share1.60
1.37
0.23
16.8 %Cash flows provided by operating activities313.1
288.6
24.5
8.5 %Adjusted EBITDA348.8
313.6
35.2
11.2 %Adjusted free cash flow193.8
222.4
(28.6)
(12.9) %







(Actual Amounts)






Discharges67,763
64,985


4.3 %   Same-store discharge growth





1.6 %Net patient revenue per discharge$      22,633
$      21,816


3.7 %See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure."We are very pleased with our start to 2026 as first quarter revenue increased 9.0% and Adjusted EBITDA grew 11.2%," said Mark Tarr, President and Chief Executive Officer. "During the quarter, we continued to expand our capacity to treat patients in need of inpatient rehabilitation services, opening a new 49-bed hospital in Irmo, South Carolina, and adding 44 beds across existing facilities. For the full-year 2026, we expect to open eight hospitals with a total of 389 beds and add approximately 175 beds to existing hospitals. Our value proposition and operating strategy continue to be validated and we remain highly optimistic about the long-term prospects of our business."2026 Guidance The Company increased its full-year guidance as follows: 
Full-Year 2026 Guidance
Previous Guidance
Updated Guidance
(In Millions, Except Per Share Data)Net operating revenue$6,365 to $6,465
$6,375 to $6,470Adjusted EBITDA$1,340 to $1,380
$1,350 to $1,380Adjusted earnings per share from continuing operations
     attributable to Encompass Health$5.81 to $6.10
$5.89 to $6.11For considerations regarding the Company's 2026 guidance, see the supplemental information posted on the Company's website at http://investor.encompasshealth.com. See also the "Other information" section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.Earnings conference call and webcastThe Company will host an investor conference call at 10:00 a.m. Eastern Time on Friday, May 1, 2026 to discuss its results for the first quarter of 2026. For reference during the call, the Company will post certain supplemental information at http://investor.encompasshealth.com.The conference call may be accessed by dialing 800 267-6316 and giving the conference ID EHCQ126. International callers should dial 203 518-9783 and give the same conference ID. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available for on-line replay at http://investor.encompasshealth.com by clicking on an available link.About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™1 and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.





1From Fortune. © 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Other informationThe information in this press release is summarized and should be read in conjunction with the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the "March 2026 Form 10-Q"), when filed, as well as the Company's Current Report on Form 8-K filed on April 30, 2026 (the "Q1 Earnings Form 8-K"), to which this press release is attached as Exhibit 99.1. In addition, the Company will post supplemental information today on its website at http://investor.encompasshealth.com for reference during its May 1, 2026 earnings call.The financial data contained in the press release and supplemental information include non-GAAP financial measures, including the Company's adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. Reconciliations to their most comparable GAAP measure, except with regard to non-GAAP guidance, are included below or in the Q1 Earnings Form 8-K. Readers are encouraged to review the "Note Regarding Presentation of Non-GAAP Financial Measures" included in the Q1 Earnings Form 8-K which provides further explanation and disclosure regarding the Company's use of these non-GAAP financial measures.Excluding net operating revenues, the Company does not provide guidance on a GAAP basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise not indicative of its ongoing operating performance. Such items include government, class action, and related settlements; professional fees—accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the Company believes to be not indicative of its ongoing operations. These items cannot be reasonably predicted and will depend on several factors, including industry and market conditions, and could be material to the Company's results computed in accordance with GAAP.However, the following reasonably estimable GAAP measures for 2026 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted:Interest expense and amortization of debt discounts and fees - approximately $125 millionAmortization of debt-related items - approximately $10 millionThe Q1 Earnings Form 8-K and, when filed, the March 2026 Form 10-Q can be found on the Company's website at http://investor.encompasshealth.com and the SEC's website at www.sec.gov.Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Operations(Unaudited)

Three Months Ended March 31,
2026
2025
(In Millions, Except Per Share Data)Net operating revenues$           1,586.6
$           1,455.4Operating expenses:


Salaries and benefits818.1
762.3Other operating expenses241.9
217.5Occupancy costs15.2
14.9Supplies64.3
62.2General and administrative expenses58.2
52.3Depreciation and amortization87.3
79.2Total operating expenses1,285.0
1,188.4Loss on early extinguishment of debt0.2
—Interest expense and amortization of debt discounts and fees31.8
31.8Other income(18.7)
(2.5)Equity in net income of nonconsolidated affiliates(0.4)
(0.9)Income from continuing operations before income tax expense288.7
238.6Provision for income tax expense56.4
41.6Income from continuing operations232.3
197.0Income (loss) from discontinued operations, net of tax 15.9
(0.5)Net income248.2
196.5Less: Net income attributable to noncontrolling interests(53.7)
(45.0)Net income attributable to Encompass Health$              194.5
$              151.5



Weighted average common shares outstanding:


Basic99.2
100.5Diluted100.6
102.1Earnings per common share:


Basic earnings per share attributable to Encompass Health
     common shareholders:


Continuing operations$                1.80
$                1.50Discontinued operations0.16
—Net income$                1.96
$                1.50Diluted earnings per share attributable to Encompass Health
     common shareholders:


Continuing operations$                1.77
$                1.48Discontinued operations0.16
—Net income$                1.93
$                1.48



Amounts attributable to Encompass Health common
     shareholders:


Income from continuing operations$              178.6
$              152.0Income (loss) from discontinued operations, net of tax 15.9
(0.5)Net income attributable to Encompass Health$              194.5
$              151.5 Encompass Health Corporation and SubsidiariesCondensed Consolidated Balance Sheets(Unaudited)

March 31,
2026
December 31,
2025
(In Millions)Assets


Current assets:


Cash and cash equivalents$            110.5
$              72.2Restricted cash52.9
30.7Accounts receivable676.0
619.2Other current assets189.7
183.8Total current assets1,029.1
905.9Property and equipment, net4,216.5
4,101.6Operating lease right-of-use assets205.3
212.6Goodwill1,317.6
1,317.6Intangible assets, net300.3
308.3Other long-term assets244.4
243.7Total assets$         7,313.2
$         7,089.7Liabilities and Shareholders' Equity


Current liabilities:


Current portion of long-term debt$              42.9
$              43.6Current operating lease liabilities26.9
26.5Accounts payable204.0
178.2Accrued expenses and other current liabilities603.0
588.1Total current liabilities876.8
836.4Long-term debt, net of current portion2,530.9
2,447.2Long-term operating lease liabilities188.7
196.6Deferred income tax liabilities135.1
126.8Other long-term liabilities214.5
206.9Total liabilities3,946.0
3,813.9Commitments and contingencies


Redeemable noncontrolling interests58.8
58.3Shareholders' equity:


Encompass Health shareholders' equity2,521.7
2,438.2Noncontrolling interests786.7
779.3Total shareholders' equity3,308.4
3,217.5Total liabilities and shareholders' equity$         7,313.2
$         7,089.7 Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows(Unaudited)

Three Months Ended March 31,
2026
2025
(In Millions)Cash flows from operating activities:


Net income$               248.2
$               196.5(Income) loss from discontinued operations, net of tax (15.9)
0.5Adjustments to reconcile net income to net cash provided by
  operating activities—


Depreciation and amortization87.3
79.2Stock-based compensation11.5
9.5Deferred tax expense8.5
8.8(Gain) loss on investments(16.2)
0.1Other, net2.3
2.2Change in assets and liabilities, net of acquisitions—


Accounts receivable(53.2)
(24.7)Other assets(11.6)
0.7Accounts payable(2.0)
(2.1)Other liabilities33.0
18.6Net cash provided by (used in) operating activities of
  discontinued operations21.2
(0.7)Total adjustments80.8
91.6Net cash provided by operating activities313.1
288.6Cash flows from investing activities:


Purchases of property, equipment, and intangible assets(162.4)
(163.1)Proceeds from sale of restricted investments42.9
11.0Purchases of restricted investments(26.4)
(2.3)Other, net(4.2)
(4.1)Net cash used in investing activities(150.1)
(158.5)Cash flows from financing activities:


Borrowings on revolving credit facility420.0
60.0Payments on revolving credit facility(330.0)
(80.0)Repurchases of common stock, including fees and expenses(71.6)
(32.1)Dividends paid on common stock(20.3)
(18.0)Distributions paid to noncontrolling interests of consolidated
  affiliates(57.8)
(32.9)Taxes paid on behalf of employees for shares withheld(30.9)
(19.8)Other, net(11.9)
(7.6)Net cash used in financing activities(102.5)
(130.4)Increase (decrease) in cash, cash equivalents, and restriced cash60.5
(0.3)Cash, cash equivalents, and restricted cash at beginning of
period102.9
123.1Cash, cash equivalents, and restricted cash at end of period$               163.4
$               122.8 Encompass Health Corporation and SubsidiariesSupplemental InformationEarnings Per Share

Three Months Ended March 31,
2026
2025
(In Millions, Except Per Share Data)Adjusted EBITDA$               348.8
$               313.6Depreciation and amortization(87.3)
(79.2)Interest expense and amortization of debt discounts and fees(31.8)
(31.8)Stock-based compensation(11.5)
(9.5)Loss on disposal or impairment of assets(0.3)
(0.2)
217.9
192.9Items not indicative of ongoing operating performance:


Loss on early extinguishment of debt(0.2)
—Change in fair market value of marketable securities(0.2)
0.7Gain on sale of Gamma Knife17.5
—Pre-tax income235.0
193.6Income tax expense(56.4)
(41.6)Income from continuing operations (1)$               178.6
$               152.0



Basic shares99.2
100.5Diluted shares100.6
102.1



Basic earnings per share (1)$                 1.80
$                 1.50Diluted earnings per share (1)$                 1.77
$                 1.48

(1)Income from continuing operations attributable to Encompass Health Encompass Health Corporation and SubsidiariesSupplemental InformationAdjusted Earnings Per Share

Three Months Ended March 31,
2026
2025



Earnings per share, as reported$            1.77
$            1.48Adjustments, net of tax:


Income tax adjustments(0.05)
(0.12)Gain on sale of Gamma Knife(0.13)
—Adjusted earnings per share*$            1.60
$            1.37

*Adjusted EPS may not sum due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA

Three Months Ended March 31,
2026
2025
(In Millions)Net cash provided by operating activities$               313.1
$               288.6Interest expense and amortization of debt discounts and fees31.8
31.8Gain (loss) on investments, excluding impairments16.2
(0.1)Equity in net income of nonconsolidated affiliates0.4
0.9Net income attributable to noncontrolling interests in continuing
     operations(53.7)
(45.0)Amortization of debt-related items(2.4)
(2.4)Distributions from nonconsolidated affiliates(0.1)
(0.5)Current portion of income tax expense47.9
32.8Change in assets and liabilities33.8
7.5Cash (provided by) used in operating activities of discontinued
     operations(21.2)
0.7Change in fair market value of marketable securities0.2
(0.7)Gain on sale of Gamma Knife(17.5)
—Other0.3
—Adjusted EBITDA$               348.8
$               313.6 Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Three Months Ended March 31, 2026


Adjustments


As
Reported
Loss on
Early
Exting. of
Debt
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
Gain on
Sale of
Gamma
Knife
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$    348.8
$         —
$              —
$                —
$         —
$    348.8Depreciation and amortization(87.3)
—
—
—
—
(87.3)Interest expense and amortization of debt discounts and fees(31.8)
—
—
—
—
(31.8)Stock-based compensation(11.5)
—
—
—
—
(11.5)Loss on disposal or impairment of assets(0.3)
—
—
—
—
(0.3)Loss on early extinguishment of debt(0.2)
0.2
—
—
—
—Change in fair market value of marketable securities(0.2)
—
—
0.2
—
—Gain on sale of Gamma Knife17.5
—
—
—
(17.5)
—Income from continuing operations before income tax
     expense235.0
0.2
—
0.2
(17.5)
217.9Provision for income tax expense(56.4)
(0.1)
(4.7)
—
4.5
(56.7)Income from continuing operations attributable to
     Encompass Health$    178.6
$        0.1
$           (4.7)
$               0.2
$    (13.0)
$    161.2Diluted earnings per share from continuing operations**$      1.77
$         —
$         (0.05)
$                —
$    (0.13)
$      1.60Diluted shares used in calculation100.6











*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Three Months Ended March 31, 2025


Adjustments


As
Reported
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$   313.6
$               —
$                —
$    313.6Depreciation and amortization(79.2)
—
—
(79.2)Interest expense and amortization of debt discounts and fees(31.8)
—
—
(31.8)Stock-based compensation(9.5)
—
—
(9.5)Loss on disposal or impairment of assets(0.2)
—
—
(0.2)Change in fair market value of marketable securities0.7
—
(0.7)
—Income from continuing operations before income tax expense193.6
—
(0.7)
192.9Provision for income tax expense(41.6)
(12.0)
0.2
(53.4)Income from continuing operations attributable to Encompass
     Health$   152.0
$         (12.0)
$            (0.5)
$    139.5Diluted earnings per share from continuing operations**$     1.48
$         (0.12)
$               —
$      1.37Diluted shares used in calculation102.1







*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Income to Adjusted EBITDA

Three Months Ended March 31,
2026
2025
(In Millions)Net income$           248.2
$           196.5(Income) loss from discontinued operations, net of tax, attributable to
     Encompass Health(15.9)
0.5Net income attributable to noncontrolling interests included in
     continuing operations(53.7)
(45.0)Provision for income tax expense56.4
41.6Interest expense and amortization of debt discounts and fees31.8
31.8Depreciation and amortization87.3
79.2Loss on early extinguishment of debt0.2
—Loss on disposal or impairment of assets0.3
0.2Stock-based compensation11.5
9.5Change in fair market value of marketable securities0.2
(0.7)Gain on sale of Gamma Knife(17.5)
—Adjusted EBITDA$           348.8
$           313.6 Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow

Three Months Ended March 31,
2026
2025
(In Millions)Net cash provided by operating activities$            313.1
$            288.6Impact of discontinued operations(21.2)
0.7Net cash provided by operating activities of continuing operations291.9
289.3Capital expenditures for maintenance(43.8)
(34.0)Distributions paid to noncontrolling interests of consolidated affiliates(57.8)
(32.9)Items not indicative of ongoing operating performance:


Transaction costs and related liabilities3.5
—Adjusted free cash flow$            193.8
$            222.4For the three months ended March 31, 2026, net cash used in investing activities was $150.1 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended March 31, 2026 was $102.5 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated affiliates, and taxes paid on behalf of employees for shares withheld partially offset by net debt borrowings.For the three months ended March 31, 2025, net cash used in investing activities was $158.5 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended March 31, 2025 was $130.4 million and resulted primarily from distributions paid to noncontrolling interests of consolidated affiliates, repurchases of common stock, net debt payments, and cash dividends paid on common stock.Encompass Health Corporation and Subsidiaries
Forward-Looking StatementsStatements contained in this press release and the supplemental information which are not historical facts, such as those relating to the business, strategy, outlook, growth targets and guidance considerations, dividend strategies, effective income tax rates, cost trends, legislative and regulatory developments or their impacts, financial guidance, ability to return value to shareholders, projected capital expenditures, acquisition opportunities, development projects, addressable market size, other balance sheet and cash flow plans, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, possible reductions or other changes in Medicaid, including Medicaid directed and supplemental payment programs and Medicaid waiver programs, which may decrease our revenues and increase our provider tax expenses; infectious disease outbreak, including the speed, depth, geographic reach and duration of its spread, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; Encompass Health's infectious disease prevention and control efforts; the demand for Encompass Health's services, including based on any downturns in the economy and consumer confidence in patient care; the price of Encompass Health's common stock as it affects Encompass Health's willingness and ability to repurchase shares and the financial and accounting effects of any repurchases; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, in acquired operations; Encompass Health's ability to attract and retain key management personnel; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's or its vendors' or partners' information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; Encompass Health's ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; increases in Medicare audit activity, including increased use of sampling and extrapolation, resulting in additional unpaid reimbursement claims and an increase in the backlog of appealed claims denials; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and deficit reduction and Encompass Health's ability to adapt operations to those changes, including in connection with the CMS inpatient rehabilitation review choice demonstration project; competitive pressures in the healthcare industry and Encompass Health's response thereto; Encompass Health's ability to obtain and retain favorable arrangements with third-party payors; Encompass Health's ability to control costs, particularly labor and employee benefit costs, including group medical expenses; adverse effects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in Encompass Health's ability to recover improperly denied claims through the administrative appeals process on a timely basis, including as part of the review choice demonstration; Encompass Health's ability to adapt to changes in the healthcare delivery system, including value-based purchasing such as the transforming episode accountability model and involvement in coordinated care initiatives or programs that may arise with its referral sources; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages, which may be worsened by infectious disease outbreaks, and the impact on Encompass Health's labor expenses from potential union activity, staffing shortages, and competitive compensation practices; general conditions in the economy and capital markets, including any instability or uncertainty related to trade war, armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in the cost of, or the decrease in the availability of, construction materials and necessary supplies, including as a result of tariffs and import restrictions; the increase in the costs of defending and insuring against alleged professional liability claims, and Encompass Health's ability to predict the estimated costs related to such claims; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025 and Form 10-Q for the quarter ended March 31, 2026, when filed.Media Contact
Polly Manuel, 205 969-4532
polly.manuel@encompasshealth.comInvestor Relations Contact
Mark Miller, 205 970-5860
mark.miller@encompasshealth.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-reports-results-for-first-quarter-2026-302759363.htmlSOURCE Encompass Health Corp.

Original: Encompass Health reports results for first quarter 2026

Encompass Health and Cookeville Regional Medical Center announce plans to build a 40-bed inpatient rehabilitation hospital in Cookeville, TennesseeApril 22, 2026 4:30 PM
PR Newswire (US)

BIRMINGHAM, Ala. and COOKEVILLE, Tenn., April 22, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) and Cookeville Regional Medical Center today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital on the Cookeville Regional Medical Center campus in Cookeville, Tennessee.







"We're proud to partner with Cookeville Regional Medical Center to address the growing demand for inpatient rehabilitation care in the Upper Cumberland Region, a premier retirement destination with a rapidly aging population," said Abe Sims, president of Encompass Health's MidAtlantic region. "By expanding access to high-quality inpatient rehabilitation services closer to home, patients will no longer need to travel to Knoxville or Nashville to regain independence following an illness or injury."The hospital will serve patients recovering from stroke and other neurological conditions, brain and spinal cord injuries, amputations and complex orthopedic issues. In addition to 24-hour nursing care, the hospital will provide physical, occupational and speech therapies to help patients restore function and improve quality of life. Care will be delivered by an interdisciplinary team of specialized nurses, therapists and physicians."This state-of-the-art facility is designed to support patients recovering from serious illness, injury or surgery," said Buffy Key, chief executive officer at Cookeville Regional Medical Center. "With advanced therapy equipment, individualized care plans and a highly trained team, we will help patients regain their independence and enhance their quality of life. A key feature that sets this facility apart is that every room will be private — reflecting both our and Encompass Health's strong commitment to patient comfort throughout the recovery process."In addition to all private patient rooms, the hospital will include a state-of-the-art therapy gym equipped with advanced rehabilitation technologies, an activities of daily living suite, an in-house dialysis suite, a dining room, a pharmacy and an outdoor therapy courtyard.Encompass Health began managing Cookeville Regional Medical Center's existing 20-bed inpatient rehabilitation unit, located on their campus, on Jan. 1, 2026. The unit will remain operational during construction of the hospital, and those 20 beds will be contributed toward the hospital once completed. The hospital, expected to open in 2027, will be part of Encompass Health's national network of inpatient rehabilitation hospitals and the Company's 12th location in Tennessee.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com 



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-and-cookeville-regional-medical-center-announce-plans-to-build-a-40-bed-inpatient-rehabilitation-hospital-in-cookeville-tennessee-302750443.htmlSOURCE Encompass Health Corp.

Original: Encompass Health and Cookeville Regional Medical Center announce plans to build a 40-bed inpatient rehabilitation hospital in Cookeville, Tennessee

Encompass Health announces annual stockholder meeting dateApril 8, 2026 7:55 AM
PR Newswire (US)

BIRMINGHAM, Ala., April 8, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) will hold its annual meeting of stockholders at 11 a.m. CT on Thursday, May 7, 2026. The meeting will be conducted by live webcast only.







Stockholders of record on March 9, 2026, may participate by visiting virtualshareholdermeeting.com/EHC2026. The meeting website will be accessible beginning 15 minutes prior to the meeting. To participate in the meeting or vote at the meeting, stockholders must enter the 16-digit control number included on their Notice of Internet Availability of Proxy Materials or their proxy card if they received the proxy materials by electronic or physical mail.For those not able to attend the virtual event live, the audio webcast may be replayed through an archived link on the same website following the meeting.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Media contact: 
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com  



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-annual-stockholder-meeting-date-302736998.htmlSOURCE Encompass Health Corp.

Original: Encompass Health announces annual stockholder meeting date

Encompass Health announces date of 2026 first-quarter earnings callApril 7, 2026 4:30 PM
PR Newswire (US)

BIRMINGHAM, Ala., April 7, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its first quarter ended March 31, 2026, after the market closes on Thursday, April 30, 2026. The Company will host an investor conference call at 10 a.m. ET on Friday, May 1, 2026, to discuss its results.







The conference call may be accessed by dialing 800-267-6316 and providing the conference ID EHCQ126. International callers should dial 203-518-9783 and provide the same conference ID. Please call approximately 10 minutes before the start of the call to ensure you are connected.A live webcast and an online replay of the conference call can be found on the Company's investor website.About Encompass Health Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact: 
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-date-of-2026-first-quarter-earnings-call-302735892.htmlSOURCE Encompass Health Corp.

Original: Encompass Health announces date of 2026 first-quarter earnings call

Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, DelawareMarch 18, 2026 4:30 PM
PR Newswire (US)

BIRMINGHAM, Ala., and BEAR, Del., March 18, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital in Bear, Delaware.







The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain and spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies designed to help patients restore function and improve their quality of life. Care will be provided by specialized nurses, therapists and physicians.The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies, an activities of daily living suite, an in-house dialysis suite, and a dining room, pharmacy and therapy courtyard."Expanding Encompass Health's footprint in Delaware is truly exciting," said Mat Gooch, president of Encompass Health's Northeast region. "This hospital will bring residents of New Castle county and surrounding areas greater access to high-quality, specialized rehabilitation care close to where they live. We're eager to break ground on this project and look forward to supporting patients as they regain independence and get back to what matters most."The hospital will be part of Encompass Health's national network of rehabilitation hospitals and its second location in Delaware, with an existing location in Middletown.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor Relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-plans-to-build-a-40-bed-inpatient-rehabilitation-hospital-in-bear-delaware-302717759.htmlSOURCE Encompass Health Corp.

Original: Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Bear, Delaware

Encompass Health Rehabilitation Hospital of Irmo now open in South CarolinaMarch 3, 2026 1:54 PM
PR Newswire (US)

BIRMINGHAM, Ala. and IRMO, S.C., March 3, 2026 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Irmo. The 49-bed inpatient rehabilitation hospital is now accepting patients.







The more than 53,000-square-foot, freestanding hospital provides essential rehabilitation services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain functional ability, independence and quality of life. Patients receive a minimum of three hours of intensive physical, occupational and/or speech therapy five days each week, as well as frequent physician visits and 24-hour nursing care. An interdisciplinary team of highly specialized nurses, therapists and physicians create customized treatment plans to meet each patient's unique recovery goals."We are thrilled that Encompass Health Irmo is now open, enabling patients in the community to recover from serious illnesses and injuries closer to home," said Ronnie Wagley, president of Encompass Health's South Atlantic region. "I'm confident our talented care team in Irmo will make a meaningful difference in patients' lives for years to come."Designed with patients' needs in mind, the hospital will offer amenities such as 49 private patient rooms; a spacious, light-filled therapy gym featuring advanced rehabilitation technologies for every mobility level; an activities of daily living suite with real-world simulated spaces; an in-house dialysis suite; a landscaped therapy courtyard with recreational areas; a dining room; an in-house pharmacy and dayroom areas.Encompass Health Irmo is the Company's 11th location in South Carolina. To learn more about the hospital, visit encompasshealth.com/locations/irmo-rehab.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 174 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Encompass Health media contact:
Polly Manuel | 205-970-5912
Media@encompasshealth.com










View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-rehabilitation-hospital-of-irmo-now-open-in-south-carolina-302702878.htmlSOURCE Encompass Health Corp.

Original: Encompass Health Rehabilitation Hospital of Irmo now open in South Carolina

Encompass Health to participate in Barclays Global Healthcare ConferenceFebruary 26, 2026 4:30 PM
PR Newswire (US)

BIRMINGHAM, Ala., Feb. 26, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held March 10-12, 2026.







Encompass Health's President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat on Wednesday, March 11, 2026, from 9-9:25 a.m. ET.The fireside chat will be broadcast live and available at investor.encompasshealth.com.About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com  



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-to-participate-in-barclays-global-healthcare-conference-302698937.htmlSOURCE Encompass Health Corp.

Original: Encompass Health to participate in Barclays Global Healthcare Conference

Encompass Health recognized for corporate excellence on Fortune and Forbes 2026 listsFebruary 24, 2026 4:30 PM
PR Newswire (US)

BIRMINGHAM, Ala., Feb. 24, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to the Fortune 2026 World's Most Admired Companies list and the Forbes 2026 America's Best Companies list. These distinctions underscore the Company's continued excellence in patient care, corporate culture and long-term performance.







This year marks the sixth consecutive year Encompass Health has been named to the Fortune World's Most Admired Companies list, one of the leading indicators of corporate reputation worldwide. The selection process begins with the largest U.S. companies by revenue and major non-U.S. companies earning more than $10 billion. Those companies are narrowed to the highest-revenue organizations in each industry across 29 countries. Fortune and Korn Ferry then conduct a corporate reputation survey in which executives, directors and analysts evaluate companies on criteria such as management quality, financial soundness, innovation, social responsibility, service quality and global competitiveness. Companies ranking in the top half of their industries earn placement on the World's Most Admired Companies list.Encompass Health was also named to the Forbes 2026 America's Best Companies list. Forbes uses a broad, data-intensive methodology to evaluate thousands of public and private U.S. companies. To compile the list, Forbes partners with multiple data and analytics firms and aggregates hundreds of measures of company quality, including customer satisfaction, financial performance, leadership consistency, workplace culture, trust indicators, media sentiment and long-term value creation. Millions of data points are analyzed to identify the top 500 companies nationwide."These recognitions speak to the exceptional work of our clinicians and the trust we've earned with patients, partners and investors," said Mark Tarr, president and chief executive officer of Encompass Health. "We are committed to helping individuals recover and regain independence, and we look forward to extending that commitment to more communities as we grow."This achievement marks another significant honor for Encompass Health, following numerous recent accolades. View all of Encompass Health's recent awards and recognitions at encompasshealth.com/why-choose-us/awards-accreditation.About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Encompass Health Media Contact:
Polly Manuel | 205-970-5912
media@encompasshealth.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-recognized-for-corporate-excellence-on-fortune-and-forbes-2026-lists-302696098.htmlSOURCE Encompass Health Corp.

Original: Encompass Health recognized for corporate excellence on Fortune and Forbes 2026 lists

Encompass Health declares dividend on common stockFebruary 19, 2026 8:44 AM
PR Newswire (US)

BIRMINGHAM, Ala., Feb. 19, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to holders of record on April 1, 2026.







About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as the timing and amounts of dividends, are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking statements speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking statements, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, a decision by the board of directors to change the dividend rate in the future; the legal, regulatory and administrative developments that occur at the federal, state and local levels; general conditions in the economy and capital markets, including any instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025, once filed.Media contact:
Polly Manuel | 205-970-5912
polly.manuel@encompasshealth.comInvestor relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com   



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-declares-dividend-on-common-stock-302692670.htmlSOURCE Encompass Health Corp.

Original: Encompass Health declares dividend on common stock

Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Flowood, MississippiFebruary 13, 2026 8:00 AM
PR Newswire (US)

BIRMINGHAM, Ala. and FLOWOOD, Miss., Feb. 13, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 50-bed inpatient rehabilitation hospital in Flowood, Mississippi.







The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain and spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies designed to help patients restore function and improve their quality of life. Care will be provided by specialized nurses, therapists and physicians.The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies, an activities of daily living suite, an in-house dialysis suite, and a dining room, pharmacy and therapy courtyard."We are proud to expand Encompass Health's presence in Mississippi," said Brad Kennedy, Encompass Health group president. "This new hospital will bring high-quality, specialized rehabilitation services closer to home for residents in the Jackson area and across central Mississippi. We look forward to breaking ground and beginning the work that will ultimately help patients regain independence and return to the lives they love."The hospital, expected to open in 2027, will be part of Encompass Health's national network of rehabilitation hospitals and its second location in Mississippi, with an existing location in Gulfport.About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forward-Looking Statements 
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including development and maintenance of relationships with referral sources; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025, when filed.Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.comInvestor Relations contact: 
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com 



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-plans-to-build-a-50-bed-inpatient-rehabilitation-hospital-in-flowood-mississippi-302687431.htmlSOURCE Encompass Health Corp.

Original: Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Flowood, Mississippi

Encompass Health reports results for fourth quarter 2025 and issues 2026 guidanceFebruary 5, 2026 4:20 PM
PR Newswire (US)

BIRMINGHAM, Ala., Feb. 5, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the fourth quarter ended December 31, 2025.







Summary results




Growth
Q4 2025
Q4 2024
Dollars
Percent
(In Millions, Except Per Share Data)Net operating revenue$      1,544.6
$      1,405.0
$     139.6
9.9 %Income from continuing operations attributable to
     Encompass Health per diluted share1.42
1.18
0.24
20.3 %Adjusted earnings per share1.46
1.17
0.29
24.8 %Cash flows provided by operating activities346.0
278.8
67.2
24.1 %Adjusted EBITDA335.6
289.6
46.0
15.9 %Adjusted free cash flow235.4
190.5
44.9
23.6 %







(Actual Amounts)






Discharges67,238
63,839


5.3 %   Same-store discharge growth





3.2 %Net patient revenue per discharge$       22,273
$       21,399


4.1 %See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure."Our Q4 performance was very strong, capping a stellar 2025," said President and Chief Executive Officer Mark Tarr. "Our 2025 revenue increased 10.5% and Adjusted EBITDA grew 14.9%. During the year, we significantly increased our capacity, adding a total of 517 inpatient rehabilitation beds via eight new hospitals and the addition of 127 beds to existing hospitals. The need for the services we provide continues to grow as the U.S. population ages. We are uniquely positioned to meet this rising demand."2026 Guidance  The Company provided the following guidance for 2026.
2026 Guidance
(In millions, Except Earnings per Share Data)Net operating revenue$6,365 to $6,465Adjusted EBITDA$1,340 to $1,380Adjusted earnings per share from continuing operations
     attributable to Encompass Health$5.81 to $6.10For considerations regarding the Company's 2026 guidance, see the supplemental information posted on the Company's website at http://investor.encompasshealth.com. See also the "Other information" section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.Earnings conference call and webcastThe Company will host an investor conference call at 10:00 a.m. Eastern Time on Friday, February 6, 2026 to discuss its results for the fourth quarter of 2025. For reference during the call, the Company will post certain supplemental information at http://investor.encompasshealth.com.The conference call may be accessed by dialing 800 267-6316 and giving the conference ID EHCQ425. International callers should dial 203 518-9783 and give the same conference ID. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available for on-line replay at http://investor.encompasshealth.com by clicking on an available link.About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 173 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™1 and Forbes' America's Best Companies. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.



1 From Fortune. © 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.Other informationThe information in this press release is summarized and should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), when filed, as well as the Company's Current Report on Form 8-K filed on February 5, 2026 (the "Q4 Earnings Form 8-K"), to which this press release is attached as Exhibit 99.1. In addition, the Company will post supplemental information today on its website at http://investor.encompasshealth.com for reference during its February 6, 2026 earnings call.The financial data contained in the press release and supplemental information include non-GAAP financial measures, including the Company's adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash flow. Reconciliations to their most comparable GAAP measure, except with regard to non-GAAP guidance, are included below or in the Q4 Earnings Form 8-K. Readers are encouraged to review the "Note Regarding Presentation of Non-GAAP Financial Measures" included in the Q4 Earnings Form 8-K which provides further explanation and disclosure regarding the Company's use of these non-GAAP financial measures.Excluding net operating revenues, the Company does not provide guidance on a GAAP basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise not indicative of its ongoing operating performance. Such items include government, class action, and related settlements; professional fees—accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the Company believes to be not indicative of its ongoing operations. These items cannot be reasonably predicted and will depend on several factors, including industry and market conditions, and could be material to the Company's results computed in accordance with GAAP.However, the following reasonably estimable GAAP measures for 2026 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted:Interest expense and amortization of debt discounts and fees - approximately $120 millionAmortization of debt-related items - approximately $10 millionThe Q4 Earnings Form 8-K and, when filed, the 2025 Form 10-K can be found on the Company's website at http://investor.encompasshealth.com and the SEC's website at www.sec.gov.Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Operations(Unaudited)

For the Three
Months Ended
December 31,
For the Year Ended
December 31,
2025
2024
2025
2024
(In Millions, Except Per Share Data)Net operating revenues$  1,544.6
$  1,405.0
$  5,935.2
$  5,373.2Operating expenses:






Salaries and benefits801.1
756.8
3,115.9
2,901.0Other operating expenses226.3
206.4
888.7
802.6Occupancy costs14.5
14.7
59.0
57.3Supplies64.5
62.3
254.4
239.0General and administrative expenses68.4
54.5
236.2
209.2Depreciation and amortization86.4
78.0
327.9
299.6Total operating expenses1,261.2
1,172.7
4,882.1
4,508.7Loss on early extinguishment of debt—
0.2
—
0.6Interest expense and amortization of debt discounts and
     fees30.2
33.0
123.2
137.4Other income(3.7)
(2.1)
(18.8)
(20.1)Equity in net income of nonconsolidated affiliates(0.8)
(0.2)
(4.3)
(3.0)Income from continuing operations before income tax
     expense257.7
201.4
953.0
749.6Provision for income tax expense55.4
37.6
192.9
150.2Income from continuing operations202.3
163.8
760.1
599.4Income (loss) from discontinued operations, net of tax 0.8
0.4
(1.0)
(2.8)Net income203.1
164.2
759.1
596.6Less: Net income attributable to noncontrolling interests(57.0)
(43.3)
(192.9)
(140.9)Net income attributable to Encompass Health$     146.1
$     120.9
$     566.2
$     455.7







Weighted average common shares outstanding:






Basic100.2
100.0
100.5
99.9Diluted102.0
102.3
102.2
102.2Earnings per common share:






Basic earnings per share attributable to Encompass
     Health common shareholders:






Continuing operations$       1.44
$       1.20
$       5.63
$       4.56Discontinued operations0.01
—
(0.01)
(0.03)Net income$       1.45
$       1.20
$       5.62
$       4.53Diluted earnings per share attributable to Encompass
     Health common shareholders:






Continuing operations$       1.42
$       1.18
$       5.55
$       4.49Discontinued operations0.01
—
(0.01)
(0.03)Net income$       1.43
$       1.18
$       5.54
$       4.46







Amounts attributable to Encompass Health common
     shareholders:






Income from continuing operations$     145.3
$     120.5
$     567.2
$     458.5Income (loss) from discontinued operations, net of tax 0.8
0.4
(1.0)
(2.8)Net income attributable to Encompass Health$     146.1
$     120.9
$     566.2
$     455.7 Encompass Health Corporation and SubsidiariesCondensed Consolidated Balance Sheets(Unaudited)

As of December 31,
2025
2024
(In Millions)Assets


Current assets:


Cash and cash equivalents$                72.2
$                85.4Restricted cash30.7
37.7Accounts receivable619.2
598.8Prepaid expenses53.9
42.3Other current assets129.9
122.7Total current assets905.9
886.9Property and equipment, net4,101.6
3,643.1Operating lease right-of-use assets212.6
203.7Goodwill1,317.6
1,284.0Intangible assets, net308.3
297.8Other long-term assets243.7
219.2Total assets$           7,089.7
$           6,534.7Liabilities and Shareholders' Equity


Current liabilities:


Current portion of long-term debt$                43.6
$              138.6Current operating lease liabilities26.5
26.3Accounts payable178.2
171.0Accrued payroll243.7
227.9Accrued distributions54.8
31.4Other current liabilities289.6
245.8Total current liabilities836.4
841.0Long-term debt, net of current portion2,447.2
2,359.2Long-term operating lease liabilities196.6
189.7Self-insured risks153.1
138.6Deferred income tax liabilities126.8
105.2Other long-term liabilities53.8
51.8Total liabilities3,813.9
3,685.5Commitments and contingencies


Redeemable noncontrolling interests58.3
56.5Shareholders' equity:


Encompass Health shareholders' equity2,438.2
2,067.0Noncontrolling interests779.3
725.7Total shareholders' equity3,217.5
2,792.7Total liabilities and shareholders' equity$           7,089.7
$           6,534.7 Encompass Health Corporation and SubsidiariesCondensed Consolidated Statements of Cash Flows(Unaudited)

For the Year Ended
December 31,
2025
2024
(In Millions)Cash flows from operating activities:


Net income$            759.1
$            596.6Loss from discontinued operations, net of tax1.0
2.8Adjustments to reconcile net income to net cash provided by operating
     activities—


Depreciation and amortization327.9
299.6Amortization of debt-related items9.6
9.7Equity in net income of nonconsolidated affiliates(4.3)
(3.0)Distributions from nonconsolidated affiliates4.1
4.0Stock-based compensation56.5
48.3Deferred tax expense22.3
10.7Other, net(3.5)
15.3Change in assets and liabilities, net of acquisitions—


Accounts receivable(15.2)
3.0Prepaid expenses and other assets(31.2)
(57.3)Accounts payable(22.6)
3.0Accrued payroll15.9
20.4Other liabilities57.4
52.8Net cash used in operating activities of discontinued operations(1.4)
(3.1)Total adjustments415.5
403.4Net cash provided by operating activities1,175.6
1,002.8Cash flows from investing activities:


Purchases of property, equipment, and intangible assets(736.4)
(642.5)Proceeds from sale of restricted investments172.8
18.9Purchases of restricted investments(184.4)
(22.5)Other, net(16.6)
(7.2)Net cash used in investing activities(764.6)
(653.3)Cash flows from financing activities:


Principal payments on debt, including pre-payments(115.1)
(255.2)Principal borrowings on notes—
15.0Borrowings on revolving credit facility220.0
80.0Payments on revolving credit facility(110.0)
(60.0)Principal payments under finance lease obligations(23.9)
(21.8)Repurchases of common stock, including fees and expenses(158.0)
(31.1)Dividends paid on common stock(71.1)
(62.8)Distributions paid to noncontrolling interests of consolidated affiliates(152.1)
(125.0)Taxes paid on behalf of employees for shares withheld(20.0)
(12.1)Contributions from noncontrolling interests of consolidated affiliates1.8
140.4Other, net(2.8)
2.0Net cash used in financing activities(431.2)
(330.6)(Decrease) increase in cash, cash equivalents, and restricted cash(20.2)
18.9Cash, cash equivalents, and restricted cash at beginning of period123.1
104.2Cash, cash equivalents, and restricted cash at end of period$            102.9
$            123.1 Encompass Health Corporation and SubsidiariesSupplemental InformationEarnings Per Share

Q4
Year Ended
2025
2024
2025
2024
(In Millions, Except Per Share Data)Adjusted EBITDA$     335.6
$     289.6
$  1,267.9
$  1,103.7Depreciation and amortization(86.4)
(78.0)
(327.9)
(299.6)Interest expense and amortization of debt discounts
     and fees(30.2)
(33.0)
(123.2)
(137.4)Stock-based compensation(18.4)
(12.5)
(56.5)
(48.3)Loss on disposal or impairment of assets(0.3)
(6.1)
(2.7)
(17.4)
200.3
160.0
757.6
601.0Items not indicative of ongoing operating performance:






Loss on early extinguishment of debt—
(0.2)
—
(0.6)Change in fair market value of marketable securities0.4
(1.7)
2.5
1.0Asset impairment impact on noncontrolling interests—
—
—
7.3Pre-tax income200.7
158.1
760.1
608.7Income tax expense(55.4)
(37.6)
(192.9)
(150.2)Income from continuing operations (1)$     145.3
$     120.5
$     567.2
$     458.5







Basic shares100.2
100.0
100.5
99.9Diluted shares102.0
102.3
102.2
102.2







Basic earnings per share (1)$       1.44
$       1.20
$       5.63
$       4.56Diluted earnings per share (1)$       1.42
$       1.18
$       5.55
$       4.49

(1) Income from continuing operations attributable to Encompass Health Encompass Health Corporation and SubsidiariesSupplemental InformationAdjusted Earnings Per Share

Q4
Year Ended
2025
2024
2025
2024







Earnings per share, as reported$      1.42
$    1.18
$      5.55
$      4.49Adjustments, net of tax:






Asset impairment impact—
—
—
0.02Income tax adjustments0.04
(0.03)
(0.08)
(0.08)Change in fair market value of marketable securities—
0.01
(0.02)
(0.01)Adjusted earnings per share*$      1.46
$    1.17
$      5.45
$      4.43

*Adjusted EPS may not sum due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA

Q4
Year Ended
2025
2024
2025
2024
(In Millions)Net cash provided by operating activities$     346.0
$     278.8
$  1,175.6
$  1,002.8Interest expense and amortization of debt discounts and
     fees30.2
33.0
123.2
137.4(Loss) gain on sale of investments, excluding impairments(0.3)
(3.1)
5.9
2.7Equity in net income of nonconsolidated affiliates0.8
0.2
4.3
3.0Net income attributable to noncontrolling interests in
     continuing operations(57.0)
(43.3)
(192.9)
(140.9)Amortization of debt-related items(2.4)
(2.4)
(9.6)
(9.7)Distributions from nonconsolidated affiliates(2.7)
(0.9)
(4.1)
(4.0)Current portion of income tax expense36.3
29.0
170.6
139.5Change in assets and liabilities(13.9)
(2.8)
(4.3)
(21.9)Cash (provided by) used in operating activities of
     discontinued operations(1.1)
(0.6)
1.4
3.1Asset impairment impact on noncontrolling interests—
—
—
(7.3)Change in fair market value of marketable securities(0.4)
1.7
(2.5)
(1.0)Other0.1
—
0.3
—Adjusted EBITDA$     335.6
$     289.6
$  1,267.9
$  1,103.7 Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Three Months Ended December 31, 2025


Adjustments


As
Reported
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$    335.6
$                —
$                   —
$     335.6Depreciation and amortization(86.4)
—
—
(86.4)Interest expense and amortization of debt discounts and fees(30.2)
—
—
(30.2)Stock-based compensation(18.4)
—
—
(18.4)Loss on disposal or impairment of assets(0.3)
—
—
(0.3)Change in fair market value of marketable securities0.4
—
(0.4)
—Income from continuing operations before income tax expense200.7
—
(0.4)
200.3Provision for income tax expense(55.4)
3.9
—
(51.5)Income from continuing operations attributable to Encompass Health$    145.3
$             3.9
$                (0.4)
$     148.8Diluted earnings per share from continuing operations**$      1.42
$           0.04
$                   —
$       1.46Diluted shares used in calculation102.0







*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Three Months Ended December 31, 2024


Adjustments


As
Reported
Loss on
Early
Exting.
of Debt
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$    289.6
$        —
$                —
$                  —
$     289.6Depreciation and amortization(78.0)
—
—
—
(78.0)Interest expense and amortization of debt discounts and fees(33.0)
—
—
—
(33.0)Stock-based compensation(12.5)
—
—
—
(12.5)Loss on disposal or impairment of assets(6.1)
—
—
—
(6.1)Loss on early extinguishment of debt(0.2)
0.2
—
—
—Change in fair market value of marketable securities(1.7)
—
—
1.7
—Income from continuing operations before income tax expense158.1
0.2
—
1.7
160.0Provision for income tax expense(37.6)
(0.1)
(2.6)
(0.4)
(40.7)Income from continuing operations attributable to Encompass
     Health$    120.5
$       0.1
$             (2.6)
$                1.3
$     119.3 Diluted earnings per share from continuing operations**$      1.18
$        —
$           (0.03)
$              0.01
$       1.17 Diluted shares used in calculation102.3









*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Year Ended December 31, 2025


Adjustments


As
Reported
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$ 1,267.9
$               —
$                  —
$  1,267.9Depreciation and amortization(327.9)
—
—
(327.9)Interest expense and amortization of debt discounts and fees(123.2)
—
—
(123.2)Stock-based compensation(56.5)
—
—
(56.5)Loss on disposal or impairment of assets(2.7)
—
—
(2.7)Change in fair market value of marketable securities2.5
—
(2.5)
—Income from continuing operations before income tax expense760.1
—
(2.5)
757.6Provision for income tax expense(192.9)
(7.9)
0.6
(200.2)Income from continuing operations attributable to Encompass Health$    567.2
$           (7.9)
$               (1.9)
$     557.4Diluted earnings per share from continuing operations**$      5.55
$         (0.08)
$             (0.02)
$       5.45Diluted shares used in calculation102.2







*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

For the Year Ended December 31, 2024


Adjustments


As
Reported
Asset
Impairment
Impact
Loss on
Early
Exting.
of Debt
Income Tax
Adjustments
Change in Fair
Market Value
of Marketable
Securities
As
Adjusted
(In Millions, Except Per Share Amounts)Adjusted EBITDA*$  1,103.7
$             —
$       —
$                —
$                  —
$  1,103.7Depreciation and amortization(299.6)
—
—
—
—
(299.6)Interest expense and amortization of debt discounts and fees(137.4)
—
—
—
—
(137.4)Stock-based compensation(48.3)
—
—
—
—
(48.3)Loss on disposal or impairment of assets(17.4)
10.4
—
—
—
(7.0)Loss on early extinguishment of debt(0.6)
—
0.6
—
—
—Change in fair market value of marketable securities1.0
—
—
—
(1.0)
—Asset impairment impact on noncontrolling interests7.3
(7.3)
—
—
—
—Income from continuing operations before income tax
     expense608.7
3.1
0.6
—
(1.0)
611.4Provision for income tax expense(150.2)
(1.3)
(0.2)
(7.7)
0.3
(159.1)Income from continuing operations attributable to
     Encompass Health$    458.5
$           1.8
$     0.4
$             (7.7)
$              (0.7)
$     452.3 Diluted earnings per share from continuing operations**$      4.49
$         0.02
$      —
$           (0.08)
$            (0.01)
$       4.43 Diluted shares used in calculation102.2











*See reconciliation of net income to Adjusted EBITDA.**Adjusted EPS may not sum across due to rounding. Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Income to Adjusted EBITDA

Q4
Year Ended
2025
2024
2025
2024
(In Millions)Net income$     203.1
$    164.2
$    759.1
$     596.6(Income) loss from discontinued operations, net of tax,
     attributable to Encompass Health(0.8)
(0.4)
1.0
2.8Net income attributable to noncontrolling interests included
     in continuing operations(57.0)
(43.3)
(192.9)
(140.9)Provision for income tax expense55.4
37.6
192.9
150.2Interest expense and amortization of debt discounts and
     fees30.2
33.0
123.2
137.4Depreciation and amortization86.4
78.0
327.9
299.6Loss on early extinguishment of debt—
0.2
—
0.6Loss on disposal or impairment of assets0.3
6.1
2.7
17.4Stock-based compensation18.4
12.5
56.5
48.3Asset impairment impact on noncontrolling interests—
—
—
(7.3)Change in fair market value of marketable securities(0.4)
1.7
(2.5)
(1.0)Adjusted EBITDA$     335.6
$    289.6
$ 1,267.9
$  1,103.7 Encompass Health Corporation and SubsidiariesSupplemental InformationReconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow

Q4
Year Ended
2025
2024
2025
2024
(In Millions)Net cash provided by operating activities$     346.0
$     278.8
$  1,175.6
$  1,002.8Impact of discontinued operations(1.1)
(0.6)
1.4
3.1Net cash provided by operating activities of continuing
     operations344.9
278.2
1,177.0
1,005.9Capital expenditures for maintenance(69.0)
(50.8)
(209.5)
(184.6)Distributions paid to noncontrolling interests of
     consolidated affiliates(42.7)
(39.5)
(152.1)
(125.0)Items not indicative of ongoing operating performance:






Transaction costs and related liabilities2.2
2.6
2.5
(6.0)Adjusted free cash flow$     235.4
$     190.5
$     817.9
$     690.3For the three months ended December 31, 2025, net cash used in investing activities was $239.4 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended December 31, 2025 was $97.4 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated affiliates and cash dividends paid on common stock partially offset by net principal borrowings on debt.For the three months ended December 31, 2024, net cash used in investing activities was $203.7 million and resulted primarily from capital expenditures. Net cash used in financing activities during the three months ended December 31, 2024 was $150.9 million and resulted primarily from net debt payments, distributions paid to noncontrolling interests of consolidated affiliates, cash dividends paid on common stock, and repurchases of common stock partially offset by contributions from noncontrolling interests of consolidated affiliates.For the year ended December 31, 2025, net cash used in investing activities was $764.6 million and resulted primarily from capital expenditures. Net cash used in financing activities during the year ended December 31, 2025 was $431.2 million and resulted primarily from repurchases of common stock,  distributions paid to noncontrolling interests of consolidated affiliates, cash dividends paid on common stock and net debt payments.For the year ended December 31, 2024, net cash used in investing activities was $653.3 million and resulted primarily from capital expenditures. Net cash used in financing activities during the year ended December 31, 2024 was $330.6 million and resulted primarily from net debt payments, distributions paid to noncontrolling interests of consolidated affiliates, cash dividends paid on common stock, and repurchases of common stock partially offset by contributions from noncontrolling interests of consolidated affiliates.Encompass Health Corporation and Subsidiaries
Forward-Looking StatementsStatements contained in this press release and the supplemental information which are not historical facts, such as those relating to the business, strategy, outlook, growth targets and guidance considerations, dividend strategies, effective income tax rates, cost trends, legislative and regulatory developments or their impacts, financial guidance, ability to return value to shareholders, projected capital expenditures, acquisition opportunities, development projects, addressable market size, other balance sheet and cash flow plans, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, infectious disease outbreak, including the speed, depth, geographic reach and duration of its spread, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; Encompass Health's infectious disease prevention and control efforts; the demand for Encompass Health's services, including based on any downturns in the economy and consumer confidence in patient care; the price of Encompass Health's common stock as it affects Encompass Health's willingness and ability to repurchase shares and the financial and accounting effects of any repurchases; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, in acquired operations; Encompass Health's ability to attract and retain key management personnel; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's or its vendors' or partners' information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; Encompass Health's ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; increases in Medicare audit activity, including increased use of sampling and extrapolation, resulting in additional unpaid reimbursement claims and an increase in the backlog of appealed claims denials; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and deficit reduction and Encompass Health's ability to adapt operations to those changes, including in connection with the CMS inpatient rehabilitation review choice demonstration project; competitive pressures in the healthcare industry and Encompass Health's response thereto; Encompass Health's ability to obtain and retain favorable arrangements with third-party payors; Encompass Health's ability to control costs, particularly labor and employee benefit costs, including group medical expenses; adverse effects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in Encompass Health's ability to recover improperly denied claims through the administrative appeals process on a timely basis, including as part of the review choice demonstration; Encompass Health's ability to adapt to changes in the healthcare delivery system, including value-based purchasing such as the transforming episode accountability model and involvement in coordinated care initiatives or programs that may arise with its referral sources; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages, which may be worsened by infectious disease outbreaks, and the impact on Encompass Health's labor expenses from potential union activity, staffing shortages, and competitive compensation practices; general conditions in the economy and capital markets, including any instability or uncertainty related to trade war, armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in the cost of, or the decrease in the availability of, construction materials and necessary supplies, including as a result of tariffs and import restrictions; the increase in the costs of defending and insuring against alleged professional liability claims, and Encompass Health's ability to predict the estimated costs related to such claims; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2025, when filed.Media Contact
Polly Manuel, 205 969-4532
polly.manuel@encompasshealth.comInvestor Relations Contact
Mark Miller, 205 970-5860
mark.miller@encompasshealth.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-reports-results-for-fourth-quarter-2025-and-issues-2026-guidance-302680637.htmlSOURCE Encompass Health Corp.

Original: Encompass Health reports results for fourth quarter 2025 and issues 2026 guidance

You blew that one

Merger in the works , to be effective o1/02/2018.

Our HealthSouth $HLS valuation models imply nice upside b4 earnings Tuesday:

Fair Value Source

Obama care killing profits!!

http://www.thefiscaltimes.com/Columns/2016/06/30/Obamacare-Insurers-Are-Looking-Taxpayer-Bailout

<<< $HLS Links! >>> ~ MAC's Quick DD Links without the charts.




PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/HLS


OTC Markets Company Info ~ http://www.otcmarkets.com/stock/HLS/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/HLS/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/HLS/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/HLS/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/HLS/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/HLS/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/HLS/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/HLS/research


Google Finance Summary ~ http://www.google.com/finance?q=HLS
Google Finance News ~ http://www.google.com/finance/company_news?q=HLS
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=HLS
Google Finance Financials ~ http://www.google.com/finance?q=HLS&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=HLS
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=HLS&histperiod=weekly#


Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=HLS+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=HLS+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=HLS+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=HLS
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=HLS+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=HLS+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/HLS
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/HLS
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=HLS+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=HLS+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=HLS+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=HLS+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=HLS+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=HLS+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=HLS+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=HLS+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=HLS+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=HLS+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=HLS+Cash+Flow&annual


FINVIZ ~ http://finviz.com/quote.ashx?t=HLS&ty=c&ta=0&p=d


Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=HLS
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=HLS
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=HLS
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=HLS
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=HLS
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=HLS&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260


CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=HLS&exchange=US


Barchart Quote ~ http://barchart.com/quotes/stocks/HLS?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/HLS
Barchart Options Quotes ~ http://barchart.com/options/stocks/HLS
Barchart Technical Chart ~ http://barchart.com/charts/stocks/HLS&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/HLS&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/HLS
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=HLS
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/HLS
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/HLS
Barchart News Headlines ~ http://barchart.com/news/stocks/HLS
Barchart Profile ~ http://barchart.com/profile//HLS
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=HLS&view=key_statistics


OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=HLS&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=HLS&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=HLS&MarketTicker=NYSE&Typ=S


Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/HLS/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/HLS/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/HLS/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/HLS/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/HLS
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/HLS/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/HLS/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/HLS/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/HLS/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/HLS/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/HLS/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=HLS&sid=1795093&framed=False


The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=HLS


Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=HLS


StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=HLS&num1=567&cobrand=&mode=stock


StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=HLS
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=HLS


AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=HLS&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8


Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=HLS.PK&WTmodLOC=C4-Officers-5


StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=HLS®ion=U


Search NASDAQ ~ http://www.nasdaq.com/symbol/HLS
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/HLS/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/HLS/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/HLS/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=HLS&selected=HLS
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=HLS&selected=HLS
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/HLS/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/HLS/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/HLS/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/HLS/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/HLS/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/HLS/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/HLS/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/HLS/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/HLS/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/HLS/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/HLS/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/HLS/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/HLS/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/HLS/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=HLS&selected=HLS
NASDAQ Financials ~ http://www.nasdaq.com/symbol/HLS/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/HLS/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/HLS/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/HLS/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/HLS/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/HLS/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/HLS/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/HLS/insider-trades/sells


The Motley Fool ~ http://caps.fool.com/Ticker/HLS.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/HLS/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/HLS/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/HLS/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/HLS/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/HLS/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/HLS/Statements.aspx?source=icasittab0000009


MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=HLS


YCharts ~ http://ycharts.com/companies/HLS
YCharts Performance ~ http://ycharts.com/companies/HLS/performance
YCharts Dashboard ~ http://ycharts.com/companies/HLS/dashboard


InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=HLS&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=HLS&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=HLS&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=HLS


Zacks Quote ~ http://www.zacks.com/stock/quote/HLS
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=HLS
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=HLS


Knobias ~ http://knobias.10kwizard.com/files.php?sym=HLS


StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=HLS


Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/HLS/HOT_TOPIC.html


Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=HLS&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=HLS®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=HLS®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=HLS®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=HLS®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=HLS®ion=USA&culture=en-us


CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=HLS


TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=HLS


OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=HLS&searcharea=e&image1.x=0&image1.y=0


Insidercow ~ http://www.insidercow.com/history/company.jsp?company=HLS&B1=Search%21


Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=HLS
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=HLS&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null


YouTube Symbol Search ~ http://www.youtube.com/results?search_query=HLS


Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=HLS


Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=HLS


Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=HLS

Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=HLS
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=HLS

Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=HLS

Investorpoint ~ http://www.investorpoint.com/ enter "HLS" and click search.

Hotstocked ~ http://www.hotstocked.com/ enter "HLS" and click search.

Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=HLS

Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=HLS

DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=HLS

SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=HLS

OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=HLS

Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "HLS" and click search.

http://www.coordinatedlegal.com/SecretaryOfState.html

http://regsho.finra.org/regsho-Index.html

http://www.shortsqueeze.com/?symbol=HLS&submit=Short+Quote%99



DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=HLS
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=HLS
Check those searches for recent HLS mentions. If HLS is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS



MACDlinks

~ Thursday! $HLS ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $HLS ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=HLS&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=HLS&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=HLS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=HLS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=HLS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=HLS
Finviz: http://finviz.com/quote.ashx?t=HLS
~ BusyStock: http://busystock.com/i.php?s=HLS&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=HLS >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

~ Thursday! $HLS ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $HLS ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=HLS&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=HLS&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=HLS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=HLS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=HLS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=HLS
Finviz: http://finviz.com/quote.ashx?t=HLS
~ BusyStock: http://busystock.com/i.php?s=HLS&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=HLS >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

HLS - Ascending Triangle on watch

Very interesting...how has this lawsuit effected the stock in this company?

Ex-Chief of HealthSouth Loses Civil Suit

June 19, 2009
By JACK HEALY
http://www.nytimes.com/2009/06/19/business/19scrushy.html?_r=1&partner=rss&emc=rss

Four years ago, Richard M. Scrushy, the former chief executive of HealthSouth, walked out of a federal courthouse in Alabama and thanked God that he had been acquitted of criminal charges that he defrauded the company. But on Thursday, a state judge still found Mr. Scrushy responsible for the fraud and ordered him to pay $2.9 billion to the company's shareholders.

In his decision, the judge, Allwin E. Horn, declared that Mr. Scrushy knew about and took part in concocting false financial statements that inflated HealthSouth's earnings to meet Wall Street's expectations and to buoy the stock.

The fraud ran for seven years, totaled $2.7 billion and was "remarkable and perhaps unique" in its size and scope, the judge wrote.

"Scrushy was the C.E.O. of the fraud," Judge Horn wrote.

The ruling was a coda on an era of scandals at companies like Enron, WorldCom, Tyco International and ImClone.

"This is the last chapter in the great epic drama of major corporate scandals that we saw in the last 10 years," said Robert J. Mintz, a former federal prosecutor who followed Mr. Scrushy's criminal trial. "It in some ways closes the book on the wave of unprecedented corporate fraud we saw. This one has dragged out even longer than Enron."

For prosecutors who failed to win a conviction of Mr. Scrushy and shareholders whose HealthSouth shares crumbled after the fraud was unmasked, the judge's decision offered a belated, if anticlimactic, vindication.

"He was the orchestrator of this fraud," said Alice H. Martin, the United States attorney who unsuccessfully prosecuted Mr. Scrushy on 36 criminal counts. Ms. Martin is retiring on Friday. "That's what I'm calling my retirement gift."

While Mr. Scrushy's criminal trial in 2005 was a five-month drama that fascinated many in Alabama and drew throngs of reporters to the courtroom, this civil trial was a quieter proceeding. It lasted two weeks and was decided by a judge, and Mr. Scrushy was often not even present.

Mr. Scrushy had already been sentenced to nearly seven years in prison for bribing a former governor of Alabama, and he spent much of the civil trial in a holding cell away from the courtroom, lawyers said. He appeared in court only to testify in his own defense.

Lawyers said the judgment was the first time that Mr. Scrushy had been found liable in any courtroom for his actions at HealthSouth, which operates dozens of rehabilitation clinics and hospitals across the country. He has already been ordered to pay fines and to repay millions of dollars in bonuses. Several other executives of HealthSouth have been convicted in the case.

Mr. Scrushy has maintained his innocence and has said he knew nothing about the fraud. His lawyers did not return calls for comment on Thursday, but other lawyers connected to the case said they expected Mr. Scrushy to appeal. He is appealing his criminal conviction in the bribery case.

Lawyers for HealthSouth and shareholders said they were poised to go after Mr. Scrushy's assets, but it is doubtful they will ever squeeze anything close to $2.9 billion from him. Mr. Scrushy has sold his shares of HealthSouth -- which closed at $13.02 on Thursday -- and was estimated to have $275 million in assets in 2005, said John Haley, a lawyer for shareholders.

"The only thing that remains now is collecting on it," said Donald Q. Cochran, a law professor at Samford University in Birmingham, Ala.

http://www.nytimes.com/2009/06/19/business/19scrushy.html?_r=1&partner=rss&emc=rss

Where is everyone????????????????

fish2fish

fish fish2

Thanks. Found it.

1:5

Trout

Can someone tell me the conversion ratio from HLSH to HLS?

Ever seen this stat?


http://www.usatoday.com/money/perfi/general/2005-11-10-pink-sheets-mym_x.htm

MOVING AROUND
Number of Pink Sheets companies moved to the New York Stock Exchange, Nasdaq or American Stock Exchange:
2000 8
2001 19
2002 11
2003 10
2004 14
2005 8
Sources: Pink Sheets



Considering the thousands of stocks that are pink, that's a very small number. It's tough to pick one, but if you do bragging rights are in order.

BTW - we just had our first success....HLSH and it's guru is now in the Sanctuary.

For anyone that thinks they can do it....here's the process.

Step 1.

TF2s Draft Picks
http://www.investorshub.com/boards/board.asp?board_id=5776

Step 2.

The Transparent Flamingo 2
http://www.investorshub.com/boards/board.asp?board_id=5260

Step 3.

TF 2 Alum's - The Guru's and their Birds
http://www.investorshub.com/boards/board.asp?board_id=5775


Simple, huh?

We had the whole time!

http://www.investorshub.com/boards/board.asp?board_id=5260

Hey, check this out.

To: Creede Bighorns who wrote (272) 10/18/2006 8:37:29 PM
From: WR61499 Read Replies (1) of 274

One of your first Flamingo stocks is all grown up now and ready to fly on its own!


AP
HealthSouth Rejoining NYSE
Wednesday October 18, 12:19 pm ET
HealthSouth to Rejoin New York Stock Exchange Next Week


BIRMINGHAM, Ala. (AP) -- Medical services provider HealthSouth Corp. said Wednesday it would rejoin the New York Stock Exchange next week, 3 1/2 years after it was delisted amid revelations of a $2.7 billion accounting fraud.
ADVERTISEMENT


Shares of HealthSouth, which have been traded over the counter, will resume trading on the exchange on Oct. 26, according to a statement by Chairman Jon Hanson.

The Birmingham-based company released Hanson's remarks ahead of a meeting in which shareholders were scheduled to vote on a reverse stock split aimed at boosting share prices.

HealthSouth stock fell 8 cents to $5.20 a share in midday over-the-counter trading.

HealthSouth, which grew into a huge rehabilitation chain but is realigning its business to concentrate on post-acute care, is moving ahead with the planned divesture of its outpatient rehabilitation division, its diagnostic division and its surgical centers, Hanson said.

"All these developments represent significant milestones in HealthSouth's recovery and is a powerful symbol of the progress we have made as a company," said Hanson's statement.

Fifteen former HealthSouth executives pleaded guilty in the fraud, and jurors convicted a 16th in a trial. Fired chief executive Richard Scrushy was acquitted in the scheme, but he was later convicted in a separate government bribery scheme linked to his years at HealthSouth.

See FULL STORY: http://www.al.com/news/birminghamnews/index.ssf?/base/news/115554695586160.xml&coll=2


HealthSouth announces plan for restructuring
Monday, August 14, 2006
MICHAEL TOMBERLIN
News staff writer

HealthSouth Corp. will jettison three of its four operating divisions to become exclusively an inpatient rehabilitation company with greater growth prospects.

The new company will retain the HealthSouth name and plans to be publicly traded on the New York Stock Exchange by the end of October, with the ticker symbol "HLS." A one-for-five reverse stock split should also be completed prior to re-listing, the company will announce today.

Investors will exchange five shares of HealthSouth stock to receive one share of higher value. The company plans to hold a shareholders meeting in Birmingham soon to approve the reverse split.

The company previously has said it is exploring the sale or spinoff of its diagnostic division with Deutsche Bank.

Now the outpatient rehabilitation and surgery center divisions are also on the block, with Goldman, Sachs & Co. handling the sale or possible spinoff of those divisions.

The moves are designed to reposition HealthSouth for profitability while cutting into its debt, Jay Grinney, chief executive at HealthSouth, said in an interview with The Birmingham News.

"The growth prospects in the post-acute arena were significant, but because of our debt load we were unable to pursue those as well as pursue development opportunities in our other sectors," Grinney said.

HealthSouth's decision to retain inpatient rehabilitation was an easy one, Grinney said, given its dominance in that segment. In the second quarter of this year, the inpatient business accounted for 57.9 percent of its revenues and 86 percent of its earnings.

Inpatient has 202 facilities with 23,700 employees, 68 percent of all HealthSouth clinical employees. The majority of the 800 corporation jobs also would stay with the new HealthSouth.

"It's our largest division. It's also responsible for generating a substantial portion of our cash flow," he said. "It has tremendous growth opportunities associated with it. We've been very pleasantly surprised at how many of those opportunities are out there."

The surgery center business is the second largest division, based on the most recent quarterly earnings report, with 24.5 percent of revenues and 18.1 percent of earnings. There are 153 surgery centers with 6,400 employees.

The outpatient rehabilitation business makes up 11 percent of revenues and 6.8 percent of earnings with 606 facilities and 3,500 employees.

The diagnostic division contributed 6.6 percent of revenues and a 10.9 percent loss in the second quarter. There are 76 of those facilities with 1,260 employees.

The corporate headquarters has five facilities with 800 employees, a portion of which deal exclusively with the various divisions.

Grinney said he is not sure why the various divisions existed under HealthSouth because they have little in common and lack synergy. Each has different patients, referral sources, payors, such as Medicare and insurance companies, and information systems, making it difficult to consolidate operations.

HealthSouth will report today it had an operating loss of $28.9 million in the second quarter of this year, a $17 million improvement over the loss it reported the same period a year ago. A 3.8 percent drop in revenues was attributed largely to the impact of the much-talked-about 75 percent rule that reduces Medicare payments to inpatient rehabilitation facilities based on a set formula. Other factors included the closing of facilities and the reclassification of some surgery centers, the company said.

Most of the proceeds from the sale of the three divisions would be used to trim HealthSouth's $3.4 billion debt load, which currently equals more than six times the company's pretax earnings. A more common ratio in the health care industry is three- to four-times earnings, a threshold HealthSouth aims to be below in five years, according to John Workman, HealthSouth's chief financial officer.

Four companies?

The shedding of the divisions could come in the form of a sale to an existing company or could be a spinoff with independent financial backing or possibly through a separate public stock offering. Grinney said it is possible Birmingham could end up with four separate health care company where it currently has one.

"It gives us the opportunity to deleverage, but it also gives the Birmingham business community the opportunity to foster and encourage and see growth in potentially three new businesses," he said. "Each one of those, then, has the potential for growing, expanding and investing in their respective areas. That could be a very good move for Birmingham."

Grinney said the companies are ready to stand up on their own with relative ease.

"The one thing that we're very pleased with is the fact that we have assembled very strong, top-notch senior management talent in each of these divisions. Each of them is capable to taking their respective divisions and leading them in a spinoff type of environment," he added. "Because of the complexity of our ambulatory surgery division, the fact that it is a much larger division, Mike Snow, our chief operating officer, would take that division out along with Joe Clark and the senior management team that they've put together."

Workman envisions as much potential for an investor purchase of the divisions as he does for a competitor coming in and buying an entire operation.

"I think all of these have a fairly high likelihood of being separate stand-alone businesses. There is a lot of private equity money out there today, and we think there will be a lot of interest there in addition to the split-off or spinoff scenarios," Workman said. "We think it's more likely to be a financial buyer in surgery centers. In outpatient it's got chances either way. In diagnostic it will more likely be a financial buyer as well."

All four companies could possibly be on the current HealthSouth campus with the reconfiguration of the offices there.

Grinney said the spinoff or sale of the division may take more than a year to complete.

"If we can move faster, we will," he said. "We don't want to drag this out any longer than we have to."

Back on Big Board

The decision to go back on the New York Stock Exchange came after discussions with NASDAQ and NYSE.

"Both exchanges expressed a strong interest in having us listed on their exchange," Grinney said. "In the final analysis, the board believed it was important to go back to the New York Stock Exchange. It really will signal a final step in the rehabilitation of the company."

The company was listed on the Big Board from the time it went public in 1986 until it was dropped from the exchange in the wake of a $2.6 billion financial fraud that came to light in March 2003.

However, then it was listed under the "HRC" symbol. That needed to be changed, Grinney said.

"It was clearly important to have a different symbol because we are such a different company," he said.

The reverse stock split is meant to reduce the 398.24 million shares of HealthSouth that are now traded to approximately 80 million, which is more consistent with a health care company of HealthSouth's size, Workman said.

Whereas one share today trades at $4.10 based on Friday's closing price, after the reverse split, five shares will be converted into one with a value of $20.50.

The move also aims to lift the share price out of single-digit trading, where it had been even before the fraud was disclosed. It should attract institutional investors and other would-be traders who currently do not pursue companies with share prices as low as HealthSouth's.

The reverse split should also reduce transaction costs for investors due to fewer shares being traded. Announcements related to per-share earnings would also be more impressive when spread out among fewer shares.

Keeping its name

Though the financial fraud has taken a toll on the company's earnings as it struggled to clean up its finances and pay legal settlements, it apparently has not done significant damage to the HealthSouth name among the general public. The company's research into whether it should change the name has revealed there is no need to go through such a costly undertaking.

"The name HealthSouth is synonymous with high quality health care and particularly high quality rehabilitative care," Grinney said. "The name really wasn't tarnished in the local communities. In Birmingham it was."

The costs associated with a name change, even to do basic tasks like change signs and letterheads, would have been enormous.

"It would have been at least a $20 million investment at a time when we don't exactly have $20 million lying around," Grinney said. "There was such brand equity, particularly in rehabilitative care, that it made sense to keep that part of the legacy."

As has become common for the company during a major announcement, Grinney reiterated HealthSouth will remain based in Birmingham.

"We do that primarily for the rabble-rousers and the convicted felons out there trying to mislead the public about our intentions," Grinney said. "Clearly we have absolutely no desire to move."

Great move today!! Back over $4. by the end of the month? Any predictions. It is great that we are off the "pinks". O.C.B.B. is a "start" in the right direction.

Wow that is alot.Been watching for a entry into it again.I missed the $3.50 last time!

13:30 HLSH HealthSouth Corporation Common Stock 07/31/2006 Added to OTCBB (HLSH) **

http://www.otcbb.com/asp/dailylist_detail.asp?d=07/28/2006&mkt_ctg=NON-OTCBB

HLSH short interest:

#msg-12240731

Security Name Security Symbol OTC Market Current Shares Short Average Daily Share Volume Days to Cover
HEALTHSOUTH CP HLSH NBB 24,505,025 1,967,609 12.45

You can say that again, what a mess Yahoo has made of their format.

Loved this posters expression of his dissatifaction LOL :

Hi, I am the Project Manager for the new Yahoo Message Boards. I just wanted to let you all know that we will be adding even more new features to the stunning new boards next week:

1) Starting next Monday, all new posts will automatically be translated into Norwegian. Our Yahoo Finance development team decided that users would want this, and since we do not speak directly to users before updating our site, we will assume this is a highly desired feature. The brilliant Stanford Ph.D.'s we hired to update the site thought it would be cool! Due to disk storage issues, we regret that we will no longer be able to offer your posts in English. Please learn Norwegian, and let us know how it goes on our Feedback form! We read every form you send us!

2) As you know, we recently stopped listing stock board posts chronologically, and went to a thread-based system. We feel that stock investors do not need to clearly see the latest posts in chronological order, during the trading day, and our Ph.D. geniuses from Stanford think you would prefer to dig through threads to find old posts on your stocks. More importantly, later this month, we will be removing the dates and times from all posts, and then in September we plan to mix them all up randomly. We hope that you are not inconvenienced by reading 8 year old posts when making investment decisions. Please use the helpful Feedback form to let us know what you think. We read every one!

3) As you may know, in the Beta we switched from a simple and effective system of "recommending" posts with a click, to a more complex one in which you rate posts with stars. Of course, you can only see the number of stars for the first post in a thread, but we feel this is better even if no one ever uses it. Our Ph.D. developers informed us that "complex" equals "better". So next month, we will replace the star system with a new even more complex one, in which you will manually calculate the cube root of how much you like the post on a scale of 3.4 to 11, and then divide by pi. Please let us know what you think on the Feedback form, which next month will only accept entries in Hexadecimal. We read every post.

Finally, just to get you excited and build some anticipation, I wanted to let you know that our Ph.D.'s are working on a new feature for 2007. Posts will be automatically scanned for keywords by our cool super-complex search technology, to determine if they would be better suited to a different stock board, and if so, they will be automatically moved. We feel the slight inconvenience of having posts moved around by the system will be outweighed by how cool the technology is!

Regards,

http://messages.finance.yahoo.com/Healthcare/Healthcare_Facilities/threadview?m=tm&bn=8761&t...

Yahoo board went to new format which sucks, welcome to ihub!

Sorry wrong board HLSH

Did anyone receive div yet.

teste

The strange order amount has 2 explanations that I have heard:
1. It's a mistake (fat fingered)
2. It's on purpose to screw up the TA people

GL

Healthsouth Basing formation is ongoing. (Powerful moves spring from long basing formations.) CMF shows accumulation and volume levels consistently rise on minor uptrends and evaporate on downtrends. Notice this most recent sell-off (4/11) occurred on relatively light volume. (1.8 million I believe). Then support kicks in on schedule at the 4.70 level (over 6 million shares.)

I believe what's occured recently (following the investor update on March 31.) is disappointment that relisting was bumped back to 3rd quarter of 06. (Stocks are very moody.)

The 4.70 level is very long term support going back into 04. Until there is any real selling volume to the downside, I wouldn't worry too much about this basing pattern.

I do have one question. Why is it that on high volume "event" days (like yesterday 4/12) weird prices seem to print (4.23 yesterday) Do the market makers intentionally throw this price into to the mix as a stop gunning exercise or is it just a horrible fill? (Why would any trade take place at that price level which is so out of bounds?) --It bugs me because it screws up my equivolume charts.

Volume Spikes everywhere. I like to look at the Equivolume chart and imagine where I am "in the city". (Visualize driving a car through the "Buildings of Volume Histogram City.") We're definitely entering the financial district.

Pressure is building. Investor conference is coming up. We're halfway to relisting. The $5 base-forming and ascending wedge are printing on my charts. Also, those 3 high volume spikes above $5 all point to a bull wanting to charge.

A break above 5.33 would be a buy according to P&F charts. Elliot Wave suggests 5.60 level as the start of the 3rd wave.